Τόμος 28 (2010) – Τεύχος 2 – Άρθρο 10 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Ελληνική Έκδοση – Volume 28 (2010) – Issue 2 – Article 10 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-Greek Edition

Στέργιος Σαββάτης¹, Τζωρτζ Δαδούς², Αικατερίνη Μαχτοπούλου³

¹Αναπληρωτής Διευθυντής Ε.Σ.Υ., ²Λέκτορας Β΄ Καρδιολογική Κλινική, ³Ιατρός Καρδιολόγος, Υποψήφια Διδάκτωρ, Αριστοτέλειο Πανεπιστήμιο, Θεσσαλονίκη, Ελλάς

Stergios Savvatis¹, George Dadous², Catherine Mahtopoulou³

¹Cardiologist, Assoc. Chairman, ²Cardiologist, Lecturer, ³Cardiologist, 2^nd Department of Cardiology, Hippokration General Hospital, Aristotelian University, Thessaloniki, Hellas

2. Moss A.J., Hall W.J., Cannom D.S., et al.: Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmias (MADITT). N. Eng. J. Med 335: 1933-1940 (1996)

3. Bardy G.H., Lee K.L., Mark D.B., et al.: Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N. Eng. J. Med. 352: 225-237 (2005)

4. Bristow M.R., Saxon L.A., Bohemer J., et al.: Cardiac resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N. Eng. J. Med. 350: 2140-2150 (2004)

5. Reynolds M.R., Josephson M.E.: MADITT II (Second Multicenter Automated Defibrillator Implantation Trial) debate: risk stratification, costs and public policy. Circulation 108: 1779-1783 (2003)

6. Gold M.R., Bloomfield D.M., Anderson K.P., et al.: A comparison of T Wave alternans, signal averaged electrocardiography and programmed ventricular stimulate for arrhythmia risk stratification. J. Am. Coll. Cardiol. 36: 2247-2253 (2000)

7. Smith J.M., Clancy E., Ruskin J., Cohen R.: Electrical alternans and cardiac electrical instability. Circulation 77: 110-121 (1988)

8. Rosenbaum D.S., Jackson L.E., Smith J.M., Garan H., Ruskin N.J., Cohen R.J.: Electrical alternans and vulnerability to ventricular arrhythmias. N. Eng. J. Med. 330: 235-241 (1994)

9. Narayan S.M., Smith J.M.: Exploiting rate hysteresis in repolarization alternans to optimize the sensitivity and specificity for ventricular tachycardia. J. Am. Coll. Cardiol. 35: 1485-1492 (2000)

10. Kleinfelt M.J., Rozanski J.J.: Alternans of the ST segment in Prinzmental’s angina. Circulation 55: 574-577 (1977)

11. Bloomfield D.M., Steinman R.C., Namerow P.B., et al.: Microvolt T Wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADITT) II conundrum. Circulation 110:1885-1889 (2004)

12. Pastore J.M., Girouard S.D., Laurita K.R., Akar F.G., Rosenbaum D.S.: Mechanism linking T-wave alternans to the genesis of cardiac fibrillation. Circulation 99: 1385-1394 (1999)

13. Pastore J.M., Rosenbaum D.S.: Role of structural barriers in the mechanism of alternans-induced reentry. Circ. Res. 87: 1157-1163 (2000)

14. Klingenheben T., Ptszynski P., Tsiakou M., Hohnloser S.: Quantitative assessment on microvolt T-wave alternans in patients with congestive heart failure. Heart Rhythm 1(Suppl. 1):S38 (2004)

15. Salerno-Uriarte J., De Ferrari G., et al. : Prognostic value of T-wave alternans in patients with heart failure due to non ischemic cardiomyopathy J. Am. Coll. Cardiol. 50: 1896-1904 (2008)

16. Cantillon D.J., Stein K.M., Markowitz S.M., et al.: Predictive value of microvolt T-wave alternans in patients with left ventricular dysfunction. J. Am. Coll. Cardiol. 50: 166-173 (2007)

17. Hohnloser H., Klingenheben T., Bloomfield D., Dabbous O., Cohen J.: Microvolt- level T-wave alternans is a powerful independent predictor of ventricular tachyarrhythmic events in pa-tients with DCM. J. Am. Coll. Cardiol. 41: 2220-2224 (2003)

18. De Ferrari G., Sanzo A.: T-wave alternans in risk stratification of patients with nonischemic dilated cardiomyopathy: Can it help to better select candidates for ICD implantation? Heart Rhythm 6: S29-S35 (2009)

19. Lown B., Verrier R.L.: Neural activity and ventricular fibrillation. N. Engl. J. Med. 294: 1165-1170 (1976)

20. Bigger J.T.,Jr, Fleiss J.L., Steinman R.C., et al.: Correlations among time and frequency domain measures of heart period variability two weeks after acute myocardial infarction. Am. J. Cardiol. 69: 891-898 (1992)

21. Akselrod S., Gordion D., Ubel F.A., et al.: Power spectrum analysis of heart rate fluctuations: A quantitative probe of beat-to-beat cardiovascular control. Science 213: 220-222 (1981)

22. Yi G., Goldman J.H., Keeling P.J., et al.: Heart rate variability in idiopathic dilated cardiomyopathy: relation to disease severity and prognosis. Heart 77: 108-114 (1997)

23. Hoffman J., Grimm W., Menz V., et al.: Heart rate variability and major arrhythmic events in patients with idiopathic dilated cardiomyopathy. PACE 19(Pt II): 1841-1844 (1996)

24. Szabo B.M., van Veldhuisen D.J., van der Veer N., et al.: Prognostic value of HRV in chronic congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy. Am. J. Cardiol. 79: 978-980 (1997)

25. Fauchier L., Babuty D., Cosnay P., et al.: Heart rate variability in idiopathic dilated cardiomyopathy: characteristics and prognostic value. J. Am. Coll. Cardiol. 30: 1009-1014 (1997)

26. Γίτσιος Κ.Θ., Παπαδόπουλος Κ.Λ., Σαββάτης Σ., Σακαντάμης Γ., Κολέτσου Ε., Παπαδόπουλος Λ. : Αναζήτηση καθυστερημένων δυναμικών εκπολώσεως σε αρρώστους με στεφανιαία νόσο και αρρώστους με μεμονωμένες κοιλιακές έκτακτες συστολές. Ελλ. Καρδιολ. Επιθ. 32: 299-303 (1991)

27. Simson M.B.: Use of signal in the terminal QRS complex to identify patients with ventricular tachycardia after myocardial infarction. Circulation 64: 265-242 (1981)

28. Gomes J.A., Mahra R., Barrera P., et al.: A comparative analysis of signal averaging of the surface QRS complex and intracardiac and epicardiac recordings of ventricular tachycardia. PACE 11: 271-282 (1998)

29. Breithardt G., Borggrefe M., Karbenn U., et al.: Prevalence of late potentials in patients with and without ventricular tachycardia: correlation and angiographic findings. Am. J. Cardiol. 49: 1932-1937 (1982)

30, Poll D.S., Marchlinski F.E., Buxton A.E,, et al.: Usefulness of programmed ventricular stimulation in idiopathic dilated cardiomyopathy without symptomatic ventricular arrhythmias. Am. J. Cardiol. 58: 992-997 (1986)

31. Itoh S., Kobayashi K., Yoneda N., et al.: Clinical study of late potentials: comparison of late potentials of myocardial infarction, cardiomyopathy and idiopathic ventricular tachycardia. Jpn Circ. J. 52: 21-29 (1988)

32. Mancini D.M., Wong K.L., Simson M.B.: Prognostic value of an abnormal signal averaged electrocardiogram in patients with non ischemic congestive cardiomyopathy. Circulation 87: 1083-1092 (1993)